Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant VWF anticorps (AA 1150-1250)

Cet anticorps Lapin Monoclonal détecte spécifiquement VWF dans IHC (f). Il présente une réactivité envers Humain.
N° du produit ABIN7127055

Aperçu rapide pour Recombinant VWF anticorps (AA 1150-1250) (ABIN7127055)

Antigène

Voir toutes VWF Anticorps
VWF (Von Willebrand Factor (VWF))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 190
  • 37
  • 27
  • 7
  • 6
  • 5
  • 1
  • 1
Humain

Hôte

  • 106
  • 103
  • 13
  • 7
  • 1
  • 1
  • 1
Lapin

Clonalité

  • 128
  • 99
  • 2
Monoclonal

Conjugué

  • 103
  • 25
  • 15
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 6
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp VWF est non-conjugé

Application

  • 139
  • 138
  • 77
  • 61
  • 57
  • 45
  • 31
  • 28
  • 25
  • 16
  • 16
  • 15
  • 9
  • 9
  • 7
  • 6
  • 5
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Épitope

    • 53
    • 21
    • 16
    • 10
    • 7
    • 6
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1150-1250

    Specificité

    Human von Willebrand factor (VWF or factor VIII-related antigen) is a 309 kDa multimeric plasma glycoprotein, important in the maintenance of hemostasis, it promotes adhesion of platelets to the sites of vascular injury by forming a molecular bridge between sub-endothelial collagen matrix and platelet-surface receptor complex GPIb-IX-V. Von Willebrand factor also acts as a chaperone for coagulation factor VIII, delivering it to the site of injury, stabilizing its heterodimeric structure and protecting it from premature clearance from plasma. Von Willebrand factor is synthesized by endothelial cells and is reported to be expressed in a number of tumors of vascular origin. IHC results aid in the classification of acute myeloid leukemia FAB type M7, angiosarcoma and epithelioid hemangioendothelioma.

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant fragment (around aa 1150-1250) of human vWF protein (exact sequence is proprietary)

    Isotype

    IgG
  • Indications d'application

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: HUVEC cells. Human tonsil.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    VWF (Von Willebrand Factor (VWF))

    Autre désignation

    VWF

    Sujet

    Coagulation Factor VIII, F8VWF, von Willebrand Antigen 2, von Willebrand Disease (vWD),von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker)
    Cellular localisation: Cytoplasm.

    Poids moléculaire

    250kDa

    ID gène

    7450, 440848

    UniProt

    P04275
Vous êtes ici:
Chat with us!